[Thank you to Richard Jeffries from the US PrEP Committee for compiling these links.]

Symposium: Antiretroviral Therapy for Prevention: The Time has Come?
Webcast

MOSY403: HIV pre-exposure prophylaxis
PowerPoint by Lynn Paxton (US)

TUPL101: Biomedical Prevention, Including Microbicides, Vaccines, Circumcision and PrEP
Webcast and Powerpoint by Ronald Gray (US)

Oral Abstract Session: ART for Prevention: Critical Issues
Webcast

CDC048: Setting priorities for future antiretroviral-based prevention research: an expert review
Abstract by Y. Halima, J. Mellors, L. Paxton, C. Dieffenbach, E. Bass, C. Collins, K. Fisher, M. Warren (US)

CDC049: Who pays if PrEP works? Potential challenges to PrEP delivery in the United States
Poster by K. Fisher, E. Bass, C. Feuer, D. Grant, L. Miller, M. Warren (US)

CDC093: Building site capacity for HIV prevention research
Abstract and poster by P. Feldblum, C. Sexton, K. MacQueen (US)

CDC098: Ethical appraisal of HIV oral pre-exposure prophylaxis trials: literature review and proposed tool
Poster by M.B. Kokolo (Canada)

MOPED023: Emerging trends in funding for research and development of new HIV prevention options
Poster by K. Fisher, C. Feuer, B. Finley, P. Harrison, W. Lee, L. Romero, S. Vuthoori, M. Warren (US)

MOPED024: Prevention research funding in a global recession: HIV vaccine and microbicide research and development (R&D) trends
Poster by K. Fisher, C. Feuer, B. Finley, P. Harrison, W. Lee, L. Romero, S. Vuthoori, M. Warren (US)

WEPEC079: Characteristics of HIV-1 serodiscordant couples enrolled into a clinical trial of antiretroviral chemoprophylaxis: the Partners PrEP study
Poster by J. Baeten, D. Donnell, A. Mujugira, P. Ndase, N. Mugo (US & Kenya), L. Kidoguchi, L. Barnes, J. Lingappa, C. Celum (US)

WEPEC080: Influence of potential symptoms and perceived efficacy on the willingness to use HIV Pre-Exposure Prophylaxis (PrEP) among Boston area men who have sex with men (MSM)
Abstract by K. Mayer, C. Johnson, M. Mimiaga, S. Safren, P. Case (US)

WEPEC082: Generation of trust between study staff and trial participants enhances participants´ compliance to study procedures in a PrEP trial in the Andes
Poster by P. Goicochea (Peru & US), L. Vargas (Peru), J. Lama (Peru), J. Bernales (Peru), V. McMahan (US), R.M. Grant (US)

WEPEC105: Comparison of acceptability towards circumcision (Circ), pre-exposure prophylaxis (PREP) and herpes simplex suppression (HSV-S) as novel HIV prevention strategies amongst truck drivers in India
Abstract by J. Schneider (US), G. Oruganti (India), S. Pasupneti (US), V. Yeldandi (US), V. Lakshmi (India), R. Dandona (India), K. Mayer (US)

WEPDC103: HIV-associated risk behavior among injecting drug users participating in an HIV pre-exposure prophylaxis trial in Bangkok
Poster by Michael Martin, S. Vanichseni, P. Suntharasamai, U. Sangkum, F. van Griensven, P.A. Mock, R. Chuachoowong, M. Leethochawalit, S. Chiamwongpaet, S. Kittimunkong, K. Choopanya (Thailand)

WEPEC081: Screening, enrollment, and follow-up of injecting drug users in an HIV pre-exposure prophylaxis trial in Bangkok
Poster by M. Martin, S. Vanichseni, P. Suntharasamai, U. Sangkum, R. Chuachoowong, M. Leethochawalit, S. Chiamwongpaet, S. Kittimunkong, P.A. Mock, J. McNicholl, L. Paxton (US), K. Choopanya (all Thailand)